GENEVA, Aug. 18 -- KINIKSA PHARMACEUTICALS, GMBH (Grafenaustrasse 56302 Zug) filed a patent application (PCT/IB2025/051326) for "CD40 ANTAGONIST OR CD154 ANTAGONIST FOR USE IN MITIGATING IMMUNE RESPONSES IN PROTEIN AND GENE THERAPIES" on Feb 07, 2025. With publication no. WO/2025/169146, the details related to the patent application was published on Aug 14, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): PAOLINI, John F. (100 Hayden Ave.Lexington, Massachusetts 02421), TESSARI, Eben (100 Hayden Ave.Lexington, Massachusetts 02421), ATAMAS, Sergei (100 Hayden Ave.Lexington, Massachusetts 02421...